| INTRODUC TI ON
Bipolar disorder (BD) is a multifactorial disorder characterized by recurrent episodes of elevated and depressed mood. According to heritability estimates, genetic factors explain 60%-80% of the variance in this disorder and recent association studies have shown that a significant proportion of its genetic liability can be attributed to common variation. [1] [2] [3] [4] Despite this relatively robust genetic component, the phenotypic and genetic heterogeneity of this mental disorder has hampered our understanding of the underlying biological mechanisms. Results: BD-and SCZ-PRSs were not significantly associated with age at disease onset. Results remained the same when analyses were stratified by site of recruitment.
Conclusions:
The current study is the largest conducted so far to investigate the association between the cumulative BD and SCZ polygenic risk and AAO in BD patients. The reported negative results suggest that such a polygenic influence, if there is any, is not large, and highlight the importance of conducting further, larger scale studies to obtain more information on the genetic architecture of this clinically relevant phenotype.
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Studies on breast cancer, colon cancer, and Alzheimer's disease have provided evidence that identifying subphenotypes underlying the clinical diagnosis can assist with patient stratification. This approach, of narrowing down the molecular heterogeneity of these complex and polygenic disorders, holds promise for the identification of the genetic factors involved. 5, 6 In BD, the presence and severity of psychotic symptoms, first episode polarity, response to lithium, functional impairments, and age at onset (AAO) are considered as promising phenotypes for the identification of putatively biologically homogenous disease-subgroups. 7, 8 The recent identification of novel lithium response-associated single nucleotide polymorphisms (SNPs) by the Consortium of Lithium Genetics (ConLiGen) and Song et al. underline the potential of this approach in BD and call for further analyses on similar well-defined subphenotypes. 9, 10 Clinical studies have shown that early-onset BD (onset prior to 18 years of age) is more severe and homogeneous than other forms of BD, and thus it is one of the most frequently examined subphenotype candidates. This subgroup is associated with a higher recurrence rate of mood episodes, higher rates of psychotic symptoms and of comorbid conditions and more frequent suicide attempts and neurocognitive impairments. 8, 11 Moreover, it has also been hypoth- However, a single study thus far has investigated the association between the cumulative genomic risk for BD (BD-PRS) and disease onset and found no significant results. 20 The association with SCZ-PRS has not been tested yet.
Given the limited knowledge of the genetic structure of AAO in BD, the aim of the current study was to use PRSs to investigate whether earlier disease onset is associated with a higher genetic liability to BD and/or SCZ in 1995 BD type 1 patients.
| ME THODS

| Subjects
The phenotypic and genetic data of patients with a lifetime diagnosis of DSM-III or DSM-IV BD type 1 were assembled from the ConLiGen, Bonn-Mannheim (BoMa) and PsyCourse samples.
Patients 21 Only patients not part of the PGC-BD1 analyses
were included in the current study. 22 PsyCourse is an ongoing, multicenter study conducted at a network of clinical sites across Germany and Austria (http://psycourse.de). 23 The phenotypic characteristics of the patients recruited at the individual sites and the respective sample sizes are presented in Supporting Information Table S1 . The reported sample sizes represent those available after quality control Approval from each institution's ethics committees was obtained.
| Genotyping and imputation
DNA was extracted from peripheral blood and samples were geno- Quality control and imputation were carried out separately for the distinct SNP arrays. Genotype imputation was performed using the 1000 Genomes reference panel using either SHAPEIT2 and IMPUTE2
(BoMa and PsyCourse) or SHAPEIT2 and minimac (ConLiGen).
25,26
The Caucasian-European origin of the samples was confirmed by principal component analysis of the genetic relationship matrix.
| Polygenic scoring
Polygenic scores were generated using PLINK v.1.9, by applying the method used by the International Schizophrenia Consortium, as described in Purcell et al. 18, 27 First, the SNPs shared between either the Psychiatric Genomics Consortiums SCZ or BD GWAS summary statistics data sets (PGC SCZ2 and PGC BD) and a merged data set of the samples included in this study were identified, resulting in N = 92 703 (SCZ) and N = 101 007 (BD) autosomal SNPs pruned for minimalizing pair-wise linkage disequilibrium. 17, 22 This harmonized set of PGC SCZ2 and PGC BD summary data was then used as the source of information on the allelic risk variants and their associated odds ratios (ORs). PRSs were calculated by multiplying the imputation probability for each risk allele by the log(OR) for each genetic variant in PGC SCZ2 and PGC BD. The resulting values were summed using all SNPs (P-value threshold, P T = 1), leading to an estimate of the SCZ or BD polygenic risk burden of each individual.
| Statistical analysis
AAO was analyzed both as a continuous and as a categorical measure; the association between AAO and either BD-or SCZ-PRS was evaluated using linear and logistic regression models, respectively.
The AAO subgroups were initially identified to represent the developmental stages, namely childhood (≤12 years), adolescence (13-18 years), or adulthood (>18 years). 
| RE SULTS
We analyzed a sample of 1995 BD type 1 patients (55.1% female).
The mean (± SD) AAO across all centers was 24.83 (±10.59) years and the AAO ranged between 6 and 67 years. The AAO was not dif- ). To ensure that the association between AAO and BDand SCZ-PRSs was not masked by these geographic differences in AAO distribution, which are well known in the literature, the same linear regressions with initial backward feature selection steps were repeated using only the USA site or the other sites. These additional analyses, similarly to the results for the full data set, found no association with the phenotype of interest. Full results, including P-values, t values and than previously assumed and therefore the current study lacked the statistical power to detect an underlying association.
| SUMMARY
To our knowledge, this is the largest study thus far to investigate the association between AAO in BD and BD-and SCZ-PRS. The results
show, in our sample of 1995 BD patients, that the polygenic burden associated with BD or SCZ risk does not influence the age at illness onset in BD. These negative results highlight the need to conduct further larger scale studies, also including environmental information, to disentangle the genetic architecture of early-onset BD.
